The tetraamine chelator outperforms HYNIC in a new technetium-99m-labelled somatostatin receptor 2 antagonist

BACKGROUND: Somatostatin receptor targeting radiopeptides are successfully being used to image, stage, and monitor patients with neuroendocrine tumours. They are exclusively agonists that internalise upon binding to the relevant receptor. According to recent reports, antagonists may be preferable to...

Descripción completa

Detalles Bibliográficos
Autores principales: Abiraj, Keelara, Ursillo, Samer, Tamma, Maria Luisa, Rylova, Svetlana N., Waser, Beatrice, Constable, Edwin C., Fani, Melpomeni, Nicolas, Guillaume P., Reubi, Jean Claude, Maecke, Helmut R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070450/
https://www.ncbi.nlm.nih.gov/pubmed/30069789
http://dx.doi.org/10.1186/s13550-018-0428-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070450/
https://www.ncbi.nlm.nih.gov/pubmed/30069789
http://dx.doi.org/10.1186/s13550-018-0428-y

Ejemplares similares